These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23385647)

  • 1. Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension.
    Gilbert K; Nian H; Yu C; Luther JM; Brown NJ
    J Hypertens; 2013 Apr; 31(4):820-9. PubMed ID: 23385647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active kallikrein response to changes in sodium-chloride intake in essential hypertensive patients.
    Ferri C; Bellini C; Carlomagno A; Desideri G; Santucci A
    J Am Soc Nephrol; 1996 Mar; 7(3):443-53. PubMed ID: 8704111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
    Campese VM; Wurgaft A; Safa M; Bianchi S
    J Nephrol; 1998; 11(6):289-95. PubMed ID: 10048494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.
    Chrysant SG; Weder AB; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Hamilton BP; Lewin AJ; Mennella RF; Kirkegaard LW; Weir MR; Weinberger MH
    Am J Hypertens; 2000 Nov; 13(11):1180-8. PubMed ID: 11078178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma.
    Melander O; von Wowern F; Frandsen E; Burri P; Willsteen G; Aurell M; Hulthén UL
    J Hypertens; 2007 Mar; 25(3):619-27. PubMed ID: 17278979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt and blood pressure responses to calcium antagonism in hypertensive patients.
    Weir MR; Hall PS; Behrens MT; Flack JM
    Hypertension; 1997 Sep; 30(3 Pt 1):422-7. PubMed ID: 9314427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Kim JA; Lee Y; Shin EK
    Diabetes Care; 2006 Feb; 29(2):195-201. PubMed ID: 16443859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in calcium levels in blood and urine during various regimens of table salt intake in patients with essential arterial hypertension].
    Tasić N; Nesović M; Djurić D; Kanjuh V
    Srp Arh Celok Lek; 2002; 130(1-2):7-12. PubMed ID: 12073292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluid, ionic and hormonal changes induced by high salt intake in salt-sensitive and salt-resistant hypertensive patients.
    de la Sierra A; Lluch MM; Coca A; Aguilera MT; Giner V; Bragulat E; Urbano-Márquez A
    Clin Sci (Lond); 1996 Aug; 91(2):155-61. PubMed ID: 8795438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal acid-base excretion in normotensive salt-sensitive humans.
    Sharma AM; Cetto C; Schorr U; Spies KP; Distler A
    Hypertension; 1993 Dec; 22(6):884-90. PubMed ID: 8244521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate lowers blood pressure in two genetic models of hypertension.
    Shatara RK; Quest DW; Wilson TW
    Can J Physiol Pharmacol; 2000 May; 78(5):367-71. PubMed ID: 10841431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt-sensitive trait of normotensive individuals is associated with altered autonomous cardiac regulation: a randomized controlled intervention study.
    Oppelaar JJ; Bouwmeester TA; Silova AA; Collard D; Wouda RD; van Duin RE; Rorije NMG; Olde Engberink RHG; Danser AHJ; van den Born BH; Vogt L
    Am J Physiol Renal Physiol; 2023 Dec; 325(6):F707-F716. PubMed ID: 37795535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.
    He FJ; Li J; Macgregor GA
    BMJ; 2013 Apr; 346():f1325. PubMed ID: 23558162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.
    Rust P; Ekmekcioglu C
    Adv Exp Med Biol; 2017; 956():61-84. PubMed ID: 27757935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term dietary salt supplementation blunts telmisartan induced increases in plasma renin activity in hypertensive patients with type 2 diabetes mellitus.
    Chen AX; Jerums G; Baqar S; Lambert E; Somarajah G; Thomas G; O'Callaghan C; MacIsaac RJ; Ekinci EI
    Clin Sci (Lond); 2015 Sep; 129(5):415-22. PubMed ID: 25849646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.
    Pimenta E; Gaddam KK; Oparil S; Aban I; Husain S; Dell'Italia LJ; Calhoun DA
    Hypertension; 2009 Sep; 54(3):475-81. PubMed ID: 19620517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the potential interaction between NaCl and prostaglandin inhibition in elderly individuals with isolated systolic hypertension.
    Alam S; Purdie DM; Johnson AG
    J Hypertens; 1999 Aug; 17(8):1195-202. PubMed ID: 10466476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of different dietary salts on the cardiovascular and renal effects of moxonidine in spontaneously hypertensive rats.
    Mervaala EM; Malmberg L; Teräväinen TL; Lähteenmäki T; Karjala K; Paakkari I; Pörsti I; Mest HJ; Vapaatalo H; Karppanen H
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):107-14. PubMed ID: 9228197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives.
    He FJ; Marciniak M; Visagie E; Markandu ND; Anand V; Dalton RN; MacGregor GA
    Hypertension; 2009 Sep; 54(3):482-8. PubMed ID: 19620514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired inactive to active kallikrein conversion in human salt-sensitive hypertension.
    Bellini C; Ferri C; Carlomagno A; Necozione S; Lepore AR; Desideri G; Santucci A
    J Am Soc Nephrol; 1996 Dec; 7(12):2565-77. PubMed ID: 8989735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.